Trial Outcomes & Findings for KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice (NCT NCT04763824)
NCT ID: NCT04763824
Last Updated: 2026-01-14
Results Overview
This outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as "Completed" if the recommended surveillance test was documented within the appropriate interval and "Not Completed" if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.
COMPLETED
NA
15 participants
Baseline (Pre-Intervention) Chart Audit
2026-01-14
Participant Flow
Clinics were the unit of assignment. The intervention was delivered at the clinic level. Outcome data were collected through retrospective, de-identified EHR chart reviews. Participants represent chart abstractions for cancer survivors seen during two independent audit periods: a baseline (pre-intervention) chart audit and a 24-month post-intervention chart audit. These audit samples were drawn from the same participating clinics but do not represent the same individual cancer survivors.
Participant milestones
| Measure |
Baseline (Pre-Intervention) Chart Audit
This arm represents the baseline, pre-intervention chart audit sample drawn from participating primary care clinics. Charts included in this audit reflect an independent analytic sample of cancer survivors being seen in the practice. Demographic characteristics were abstracted at this time point to describe the baseline sample. Analyses are descriptive and no inferential comparisons were conducted between baseline and post-intervention samples.
|
24-Month (Post-Intervention) Follow-Up Chart Audit
This arm represents the analytic sample of EHR charts reviewed at the 24-month post-intervention time point. Charts reflect an independent sample drawn from the same participating clinics and do not necessarily represent the same cancer survivors included in the baseline chart audit.
|
|---|---|---|
|
Baseline Arm
STARTED
|
138
|
0
|
|
Baseline Arm
COMPLETED
|
138
|
0
|
|
Baseline Arm
NOT COMPLETED
|
0
|
0
|
|
Post-Intervention Arm
STARTED
|
0
|
129
|
|
Post-Intervention Arm
COMPLETED
|
0
|
129
|
|
Post-Intervention Arm
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice
Baseline characteristics by cohort
| Measure |
Baseline (Pre-Intervention) Chart Audit
n=138 Participants
This arm represents the baseline, pre-intervention chart audit sample drawn from participating primary care clinics prior to implementation of the KanSurvive ECHO + Practice Facilitation intervention.
Charts included in this audit reflect an independent analytic sample of cancer survivors and do not necessarily represent the same individuals included in the baseline chart audit.
Demographic characteristics were abstracted at this time point (Baseline) to describe the post-intervention sample.
Analyses are descriptive and no inferential comparisons were conducted between baseline and post-intervention samples.
|
24-Month Follow-Up (Post-Intervention) Chart Audit
n=129 Participants
This arm represents the 24-month post-intervention chart audit sample drawn from the same participating primary care clinics following implementation of the KanSurvive ECHO + Practice Facilitation intervention.
Charts included in this audit reflect an independent analytic sample of cancer survivors and do not necessarily represent the same individuals included in the baseline chart audit.
Demographic characteristics were abstracted at this time point (Post) to describe the post-intervention sample.
Analyses are descriptive and no inferential comparisons were conducted between baseline and post-intervention samples.
|
Total
n=267 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
64.5 years
STANDARD_DEVIATION 7.7 • n=9 Participants
|
63.0 years
STANDARD_DEVIATION 9.6 • n=6 Participants
|
63.8 years
STANDARD_DEVIATION 8.65 • n=9 Participants
|
|
Sex: Female, Male
Female
|
74 Participants
n=9 Participants
|
67 Participants
n=6 Participants
|
141 Participants
n=9 Participants
|
|
Sex: Female, Male
Male
|
64 Participants
n=9 Participants
|
62 Participants
n=6 Participants
|
126 Participants
n=9 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=9 Participants
|
3 Participants
n=6 Participants
|
6 Participants
n=9 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
121 Participants
n=9 Participants
|
125 Participants
n=6 Participants
|
246 Participants
n=9 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
14 Participants
n=9 Participants
|
1 Participants
n=6 Participants
|
15 Participants
n=9 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=9 Participants
|
0 Participants
n=6 Participants
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=9 Participants
|
1 Participants
n=6 Participants
|
3 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=9 Participants
|
0 Participants
n=6 Participants
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=9 Participants
|
2 Participants
n=6 Participants
|
4 Participants
n=9 Participants
|
|
Race (NIH/OMB)
White
|
130 Participants
n=9 Participants
|
96 Participants
n=6 Participants
|
226 Participants
n=9 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=9 Participants
|
0 Participants
n=6 Participants
|
2 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=9 Participants
|
30 Participants
n=6 Participants
|
32 Participants
n=9 Participants
|
|
Number of EHR charts analyzed at baseline
|
138 EHR charts
n=9 Participants
|
129 EHR charts
n=6 Participants
|
267 EHR charts
n=9 Participants
|
PRIMARY outcome
Timeframe: Baseline (Pre-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
This outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as "Completed" if the recommended surveillance test was documented within the appropriate interval and "Not Completed" if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=138 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Tumor Surveillance Completion (Pre-Intervention)
|
126 Participants
|
PRIMARY outcome
Timeframe: 24-Month Follow-Up (Post-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.
This outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as "Completed" if the recommended surveillance test was documented within the appropriate interval and "Not Completed" if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=129 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Tumor Surveillance Completion (Post-Intervention)
|
117 Participants
|
PRIMARY outcome
Timeframe: Baseline (Pre-intervention) Chart ReviewPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
This outcome reflects whether recommended Distress Screening was completed and documented in the EHR. Distress Screening was defined as documentation of using a standardized distress assessment tool consistent with survivorship best practices. Charts were coded as "Completed" when a distress screening result was documented during the chart abstraction interval. "Not Complete" indicated missing or incomplete documentation.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=138 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Distress Screening Completion (Pre-Intervention)
|
116 Participants
|
PRIMARY outcome
Timeframe: 24-Month Follow-Up (Post-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.
This outcome reflects whether recommended Distress Screening was completed and documented in the EHR. Distress Screening was defined as documentation of using a standardized distress assessment tool consistent with survivorship best practices. Charts were coded as "Completed" when a distress screening result was documented during the chart abstraction interval. "Not Complete" indicated missing or incomplete documentation.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=129 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Distress Screening Completion (Post-Intervention)
|
116 Participants
|
PRIMARY outcome
Timeframe: Baseline (Pre-intervention) Chart ReviewPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
BMI assessment was defined as documentation of a height and weight measurement sufficient to calculate body mass index (BMI) in the electronic health record (EHR). Charts were coded as "Completed" when BMI or its components were documented within the recommended timeframe.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=138 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Body Mass Index (BMI) Assessment Completion (Pre-Intervention)
|
132 Participants
|
PRIMARY outcome
Timeframe: 24-Month Follow-Up (Post-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
BMI assessment was defined as documentation of a height and weight measurement sufficient to calculate body mass index (BMI) in the electronic health record (EHR). Charts were coded as "Completed" when BMI or its components were documented within the recommended timeframe.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=129 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Body Mass Index (BMI) Assessment Completion (Post-Intervention)
|
118 Participants
|
PRIMARY outcome
Timeframe: Baseline (Pre-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
Tobacco use screening was defined as documentation of current tobacco use status in the electronic health record (EHR). Charts were coded as "Completed" when a screening result was documented within the recommended timeframe.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=138 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Tobacco Use Screening Completion (Pre-Intervention)
|
115 Participants
|
PRIMARY outcome
Timeframe: 24-Month Follow-Up (Post-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
Tobacco use screening was defined as documentation of current tobacco use status in the electronic health record (EHR). Charts were coded as "Completed" when a screening result was documented within the recommended timeframe.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=129 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Tobacco Use Screening Completion (Post-Intervention)
|
119 Participants
|
PRIMARY outcome
Timeframe: Baseline (Pre-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
This outcome reflects whether a cancer diagnosis was documented on the patient's EHR problem list, consistent with survivorship care documentation standards. Charts were coded as "Completed" when the cancer diagnosis appeared in the structured problem list.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=138 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Cancer Diagnosis on Problem List (Pre-Intervention)
|
129 Participants
|
PRIMARY outcome
Timeframe: 24-Month Follow-Up (Post-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics
This outcome reflects whether a cancer diagnosis was documented on the patient's EHR problem list, consistent with survivorship care documentation standards. Charts were coded as "Completed" when the cancer diagnosis appeared in the structured problem list.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=129 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Cancer Diagnosis on Problem List (Post-Intervention)
|
122 Participants
|
PRIMARY outcome
Timeframe: Baseline (Pre-intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.
Family history of cancer documentation was defined as the presence of cancer-related family history information in the EHR. Charts were coded as "Completed" when documentation included a family history of cancer assessment entry.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=138 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Family History of Cancer Documentation (Pre-Intervention)
|
96 Participants
|
PRIMARY outcome
Timeframe: 24-Month Follow-Up (Post-Intervention) Chart AuditPopulation: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.
Family history of cancer documentation was defined as the presence of cancer-related family history information in the EHR. Charts were coded as "Completed" when documentation included a family history of cancer assessment entry.
Outcome measures
| Measure |
KanSurvive ECHO + Practice Facilitation
n=129 Participants
This was a single-arm, delayed-start, clinic-level design. Primary care clinics were the unit of assignment and all clinics received the same KanSurvive ECHO + practice facilitation intervention. Pre- and post-intervention data represent chart abstractions, not longitudinal follow-up of the same individuals.
|
|---|---|
|
Family History of Cancer Documentation (Post-Intervention)
|
115 Participants
|
Adverse Events
Baseline (Pre-Intervention) Chart Audit
24-Month Follow-Up (Post-Intervention) Chart Audit
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Jennifer Klemp, PhD, Principal Investigator
The University of Kansas Medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place